FEMIROZ PREGNOVA ENVEPE VOMIPREG

Dose: 12.5 to 25 mg
Single Dose: 19 (18.75)
Frequency: 6 hourly
Route: oral
Instructions:

Doxylamine Succinate also known as Doxylamine. . It is of Synthetic origin and belongs to Monoethanolamine derivative. It belongs to H1-antagonist pharmacological group on the basis of mechanism of action. The Molecular Weight of Doxylamine Succinate is 388.50.

Doxylamine Succinate is contraindicated in conditions like Hypersensitivity,Porphyria.

The severe or irreversible adverse effects of Doxylamine Succinate, which give rise to further complications include Convulsions, CNS depression, Blurred vision, Ventricular arrhythmia, Psychomotor impairment.The signs and symptoms that are produced after the acute overdosage of Doxylamine Succinate include Tachycardia, Ataxia, Tremor, Excitation, Psychosis.The symptomatic adverse reactions produced by Doxylamine Succinate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Drowsiness, Nausea and vomiting, Lassitude, Incoordination.

Doxylamine Succinate is primarily indicated in conditions like Cold, Cough, Hypersensitivity reactions, Skin diseases, and can also be given in adjunctive therapy as an alternative drug of choice in Insomnia, Pruritus.

No data regarding the interactions of Doxylamine Succinate was found.

Drug should not be given to patients suffering from Kidney dysfunction, patients suffering from Liver Malfunction, and Geriatrics.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Store . Protect from Sunlight.

Doxylamine succinate should be used with caution in prostatic hypertrophy, urinary retension, glaucoma and pyloro-duodenal obstruction. It should be used with care in hepatic disease and dose reduction may be necessary in renal impairment. Caution may be required in epilepsy. Children and elderly are more susceptible to side effects.